Evidence map›Paper›PMID 27965642›Full record

ArticleFrontiers in microbiology2016

Detection of Inter-Lineage Natural Recombination in Avian Paramyxovirus Serotype 1 Using Simplified Deep Sequencing Platform.

Dilan A Satharasinghe, Kavitha Murulitharan, Sheau W Tan, Swee K Yeap, Muhammad Munir, Aini Ideris, Abdul R Omar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Dilan A SatharasingheLaboratory of Vaccine and Immunotherapeutic, Institute of Bioscience, Universiti Putra MalaysiaSerdang, Malaysia; Faculty of Veterinary Medicine and Animal Science, University of PeradeniyaPeradeniya, Sri Lanka.
Kavitha MurulitharanLaboratory of Vaccine and Immunotherapeutic, Institute of Bioscience, Universiti Putra Malaysia Serdang, Malaysia.
Sheau W TanLaboratory of Vaccine and Immunotherapeutic, Institute of Bioscience, Universiti Putra Malaysia Serdang, Malaysia.
Swee K YeapLaboratory of Vaccine and Immunotherapeutic, Institute of Bioscience, Universiti Putra Malaysia Serdang, Malaysia.
Muhammad MunirInfection and Innate Immunity Research Group, Avian Viral Diseases, The Pirbright Institute Surrey, UK.
Aini IderisLaboratory of Vaccine and Immunotherapeutic, Institute of Bioscience, Universiti Putra MalaysiaSerdang, Malaysia; Faculty of Veterinary Medicine, Universiti Putra MalaysiaSerdang, Malaysia.
Abdul R OmarLaboratory of Vaccine and Immunotherapeutic, Institute of Bioscience, Universiti Putra MalaysiaSerdang, Malaysia; Faculty of Veterinary Medicine, Universiti Putra MalaysiaSerdang, Malaysia.
Universiti Putra Malaysia · MYThe Pirbright Institute · GBUniversity of Peradeniya · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newcastle disease virus (NDV) is a prototype member of avian paramyxovirus serotype 1 (APMV-1), which causes severe and contagious disease in the commercial poultry and wild birds. Despite extensive vaccination programs and other control measures, the disease remains endemic around the globe especially in Asia, Africa, and the Middle East. Being a single serotype, genotype II based vaccines remained most acceptable means of immunization. However, the evidence is emerging on failures of vaccines mainly due to evolving nature of the virus and higher genetic gaps between vaccine and field strains of APMV-1. Most of the epidemiological and genetic characterizations of APMVs are based on conventional methods, which are prone to mask the diverse population of viruses in complex samples. In this study, we report the application of a simple, robust, and less resource-demanding methodology for the whole genome sequencing of NDV, using next-generation sequencing (NGS) on the Illumina MiSeq platform. Using this platform, we sequenced full genomes of five virulent Malaysian NDV strains collected during 2004-2013. All isolates clustered within highly prevalent lineage 5 (specifically in lineage 5a); however, a significantly greater genetic divergence was observed in isolates collected from 2004 to 2011. Interestingly, genetic characterization of one isolate collected in 2013 (IBS025/13) shown natural recombination between lineage 2 and lineage 5. In the event of recombination, the isolate (IBS025/13) carried nucleocapsid protein consist of 55-1801 nucleotides (nts) and near-complete phosphoprotein (1804-3254 nts) genes of lineage 2 whereas surface glycoproteins (fusion, hemagglutinin-neuraminidase) and large polymerase of lineage 5. Additionally, the recombinant virus has a genome size of 15,186 nts which is characteristics for the old genotypes I-IV isolated from 1930 to 1960. Taken together, we report the occurrence of a natural recombination in circulating strains of NDV in commercial poultry using NGS methodology. These findings will not only highlight the potential of RNA viruses to evolve but also to consider the application of NGS in revealing the genetic diversity of these viruses in clinical materials. Factors that drive these evolutionary events and subsequent impact of these divergences on clinical outcome of the disease warrant future investigations.

Indexed as

avian paramyxovirus 1Newcastle disease virusnext-generation sequencingphylogenetic analysisrecombination

Identifiers

PMID27965642
PMCPMC5127838
OpenAlexW2559522898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.